0001127602-16-067704.txt : 20161118 0001127602-16-067704.hdr.sgml : 20161118 20161118101208 ACCESSION NUMBER: 0001127602-16-067704 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161116 FILED AS OF DATE: 20161118 DATE AS OF CHANGE: 20161118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LUEKE MELISSA CENTRAL INDEX KEY: 0001224663 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 162006665 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2016-11-16 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0001224663 LUEKE MELISSA 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 Exec VP, CFO Common Stock 163071 D Stock Options (Right to Buy) 16.85 2016-11-16 4 A 0 10000 0 A 2026-11-16 Common Stock 10000 10000 D These options are awarded under the 2012 Stock Incentive Plan in connection with increased responsibility as Executive Vice President, Chief Financial Officer, and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on November 16, 2020). /s/ Melissa Lueke 2016-11-18